World Cancer Day 2017
Annals of Oncology and the European Society for Medical Oncology mark World Cancer Day, February 4th 2017
Taking place under the tagline ‘We can. I can.’, World Cancer Day 2017 explores how everyone – as a collective or as individuals – can do their part to reduce the global burden of cancer.
Our collection of articles focuses on what we can do as clinicians, researchers and support services to take action, as well as what individuals can do to help prevent cancer or seek support.
We CanManagement of immune checkpoint blockade dysimmune toxicities: a collaborative position paper
S. Champiat, O. Lambotte, E. Barreau et al.
ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe
N. Cherny et al.
The obese endometrial cancer patient: how do we effectively improve morbidity and mortality in this patient population?
K. Papatla et al.
Is it possible to encourage hope in non-advanced cancer patients? We must try
C. I. Ripamonti et al.
Stepped Care Targeting Psychological Distress in Head and Neck Cancer and Lung Cancer Patients: a Randomized Controlled Trial
A. M. H. Krebber, F. Jansen, B. I. Witte et al.
Osimertinib (AZD9291)—a science-driven, collaborative approach to rapid drug design and development
The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06)
F. Strasser, D. Blum, R. von Moos et al.
I CanFruits, vegetables and lung cancer risk: a systematic review and meta-analysis
A. R. Vieira, L. Abar, S. Vingeliene et al.
Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis
S. G. Smith, I. Sestak, A. Forster et al.
Medication to reduce breast cancer risk: why is uptake low?
P. Butow et al.
Home administration of bortezomib in multiple myeloma is cost-effective and is preferred by patients compared with hospital administration: results of a prospective single-center study
A. Lassalle, P. Thomaré, C. Fronteau et al.
Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study
W. Jacot, N. Firmin, L. Roca et al.
Association between information provision and decisional conflict in cancer patients
J. A. Sim, J. S. Shin, S. M. Park et al.
Join the conversation on twitter with Annals of Oncology and #WorldCancerDay #WeCanICan
Other World Cancer Day resources from Oxford Journals: Explore our interactive infographic